Terms and Synonyms Searched:
| Terms | Search Results* | Entire Database** |
|---|---|---|
| Synonyms | ||
| zevalin | 54 studies | 108 studies |
| ibritumomab tiuxetan | 49 studies | 98 studies |
| IDEC-Y2B8 | 15 studies | 22 studies |
| ibritumomab tiuxetan | 54 studies | 108 studies |
| zevalin | 45 studies | 94 studies |
| IDEC-Y2B8 | 15 studies | 22 studies |
| tiuxetan | 50 studies | 99 studies |
| ibritumomab | 49 studies | 99 studies |
| Non-Hodgkin's Lymphoma | 53 studies | 2,999 studies |
| Diffuse Small Cleaved-Cell Lymphoma | 7 studies | 486 studies |
| Non-Hodgkin malignant lymphoma | -- | 2 studies |
| Lymphoma | 54 studies | 9,235 studies |
| Lymphomatous | 1 studies | 25 studies |
| Lymphosarcoma | -- | 1 studies |
| Non-Hodgkin's | 54 studies | 5,006 studies |
| Rituximab | 54 studies | 2,487 studies |
| Rituxan | 26 studies | 850 studies |
| mabthera | 15 studies | 605 studies |
| IDEC-C2B8 | 14 studies | 214 studies |
| C2B8 Monoclonal Antibody | 10 studies | 179 studies |
| Chimeric Anti-CD20 Antibody | 2 studies | 124 studies |
| IDEC-102 | 2 studies | 119 studies |
| -- | No studies found |
| * | Number of studies in the search results containing the term or synonym |
| ** | Number of studies in the entire database containing the term or synonym |